The Effects of Adjuvant Zoladex Plus Tamoxifen on Breast Density in Pre- or Peri-Menopausal Women With Early-Stage Breast Cancer.
Phase of Trial: Phase II/III
Latest Information Update: 07 Jun 2016
At a glance
- Drugs Goserelin (Primary) ; Tamoxifen (Primary)
- Indications Early breast cancer
- Focus Therapeutic Use
- 07 Jun 2016 Results assessing DFS and OS presented at the 52nd Annual Meeting of the American Society of Clinical Oncology.
- 16 Jul 2013 Primary endpoint 'Breast-density' has been met.
- 16 Jul 2013 Results published in the British Journal of Cancer.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History